Trial By Error: Another Nudge to Mahana’s Gasteroenterology Advisers
…sent Dr Lu and Dr di Lorenzo a follow-up nudge, similar to one I recently sent to another gastroenterology adviser, Dr Mel Heyman from University of California, San Francisco. I…
…sent Dr Lu and Dr di Lorenzo a follow-up nudge, similar to one I recently sent to another gastroenterology adviser, Dr Mel Heyman from University of California, San Francisco. I…
…and loved my black Silence=Death T-shirt. In 1988, when I moved to San Francisco to join the daily newspaper, I had to step away from street activism. It’s good to see others…
…over treatment-as-usual in reducing IBS symptom severity at 12 months. At 24 months, any benefits were neither statistically nor clinically significant. Yet a start-up company based in San Francisco licensed…
…an unblinded study relying on subjective outcomes. In January of 2020, Mahana Therapeutics, a San-Francisco start-up, announced that it had licensed the rights to the web-based program. In the trial,…
…several years ago at a film festival north of San Francisco; I had been invited to participate on a panel discussion accompanying a screening of the film. Natalie’s current project,…
Daniel Griffin provides a clinical report on COVID-19, then we discuss rapid deployment of SARS-CoV-2 testing by research laboratories in San Francisco, longitudinal observation of antibodies to SARS-CoV-2 in patients,…